Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

The Finviz API: Higher Limits, Clearer Data, and More Ways to Connect

Get Started Now

BioNexus Gene Lab Corp.

Contributing Author

Recent Articles by BioNexus Gene Lab Corp.

Oct-07	BioNexus to Build AI Applications for Malaysian Healthcare Under Exclusive CogniAI Licence BGLC +8.06% GlobeNewswire
Jul-28	BioNexus Advances VitaGuard Southeast Asia Rollout Following China Working Visit BGLC GlobeNewswire
May-29	BioNexus Gene Lab Corp. Calls for Malaysia-China Biotechnology Cooperation to Move Beyond Trade into Co-Development BGLC GlobeNewswire
Mar-11	BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard MRD Platform BGLC GlobeNewswire
Feb-23	BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman BGLC GlobeNewswire
Jan-28	BioNexus Launches Regional Deployment of VitaGuard MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN's Multi-Billion Dollar Market BGLC GlobeNewswire
Dec-03	BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard BGLC GlobeNewswire
Dec-02	BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization BGLC GlobeNewswire
Dec-01	BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard MRD Platform as Part of Strategic Alliance with Tongshu Gene BGLC GlobeNewswire
Nov-12	BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization BGLC -6.02% GlobeNewswire
Nov-10	BioNexus Gene Lab Corp. Files $100 Million Shelf Registration and Establishes $20 Million At-the-Market Program to Advance Strategic Growth Opportunities BGLC GlobeNewswire
Oct-20	BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc. BGLC GlobeNewswire
Jul-30	BioNexus Gene Lab Corp. and Fidelion Diagnostics Announce Landmark Alliance-Touted as a new "DeepSeek Moment" in Precision Oncology BGLC +60.99% GlobeNewswire
Apr-30	BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness BGLC GlobeNewswire
Apr-30	BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness BGLC GlobeNewswire
Apr-30	BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness BGLC GlobeNewswire

Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)